programas cribado cancer

ACTUALIZACIÓN BIBLIOGRÁFICA

Nota Bibliográfica

Esta Nota es una recopilación de publicaciones (artículos, informes, libros) sobre cribado de cáncer resultado de una revisión no sistemática de la literatura.

Podéis dirigir vuestros comentarios o sugerencias sobre la Nota a:

Josep A Espinás. Pla Director d'Oncología de Catalunya.
Correo electrónico: Esta dirección electrónica esta protegida contra spam bots. Necesita activar JavaScript para visualizarla

Nota bibliográfica cribado c pulmón 2014-07/08

Deppen SA, Grogan EL, Aldrich MC, Massion PP. Lung Cancer Screening and Smoking Cessation: A Teachable Moment? J Natl Cancer Inst. 2014;106(6). Available from: http://jnci.oxfordjournals.org/content/106/6/dju122.short.  doi: 10.1093/jnci/dju122.
 
Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of Lung Cancer Screening Results on Smoking Cessation. J Natl Cancer Inst. 2014;106(6). Available from: http://jnci.oxfordjournals.org/content/106/6/dju084.abstract.  doi: 10.1093/jnci/dju084.

Conclusions Smoking cessation is statistically significantly associated with screen-detected abnormality. Integration of effective smoking cessation programs within screening programs should lead to further reduction in smoking-related morbidity and mortality.

 

Nota bibliográfica cribado c pulmón 2014-06

Ashraf H, Saghir Z, Dirksen A, Pedersen JH, Thomsen LH, Døssing M, et al. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax. 2014;69(6):574–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24443174. doi: 10.1136/thoraxjnl-2013-203849. PMID: 24443174.

CONCLUSIONS: Screening with low-dose CT had no extra effect on smoking status compared with the control group, but overall the screening programme probably promoted smoking cessation

 

Nota bibliográfica cribado c pulmón 2014-05

Detterbeck FC. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue? Thorax. 2014;69(5):407–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24646660.

Manos, Daria; Seely, Jean M; Taylor, Jana; Borgaonkar, Joy; Roberts HC. The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening. Can Assoc Radiol J. 2014;65(2):121–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24758919.
 
Despite the positive outcome of the recent randomized trial of computed tomography (CT) screening for lung cancer, substantial implementation challenges remain, including the clear reporting of relative risk and suggested workup of screen-detected nodules. Based on current literature, we propose a 6-level Lung-Reporting and Data System (LU-RADS) that classifies screening CTs by the nodule with the highest malignancy risk. As the LU-RADS level increases, the risk of malignancy increases. The LU-RADS level is linked directly to suggested follow-up pathways. Compared with current narrative reporting, this structure should improve communication with patients and clinicians, and provide a data collection framework to facilitate screening program evaluation and radiologist training.

   

Nota bibliográfica cribado c pulmón 2014-04

Duffy SW, Field JK, Allgood PC, Seigneurin A. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer. 2014;110(7):1834–40. Available from: http://dx.doi.org/10.1038/bjc.2014.63.
 
Interpretation/conclusion: The predictions suggest that the intervention effect could justify the human costs. The evidence base for low-dose CT screening for lung cancer pertains almost entirely to annual screening. The benefit of biennial screening is subject to additional uncertainty but the issue merits further empirical research.

 

Nota bibliográfica cribado c pulmón 2014-03

Kussman RS. The overdiagnosis theory in lung cancer screening: does it make any sense? J Surg Oncol. 2014;109(3):177–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24249310. doi: 10.1002/jso.23491. PMID: 24249310.

   

Página 2 de 5

balidea
web desarrollada y mantenida por :